Brief: Abionyx Pharma FY Net Loss Narrows To EUR 4.2 Million

Abionyx Pharma SA

29/03/2023 17:39

March 29 (Reuters) - Abionyx Pharma SA  ABNX.PA :
    * FY NET LOSS EUR 4.2 MILLION VERSUS LOSS EUR 5.8 MILLION
YEAR AGO
    * FY TURNOVER EUR 5.3 MILLION VERSUS EUR 0.7 MILLION YEAR
AGO
    * CASH AND CASH EQUIVALENTS AMOUNTED TO €4,046 THOUSAND AS
OF
DECEMBER 31, 2022 COMPARED TO €7,935 THOUSAND AS OF DECEMBER 31,
2021.
    * ALL PRECLINICAL AND CLINICAL RESULTS OF 2022 AND THIS
BEGINNING
OF YEAR PREFIGURE A FURTHER ACCELERATION OF DEVELOPMENT OF
NATURAL APOA-I IN SEVERE KIDNEY DISEASES
    * FY OPERATING LOSS EUR 4.1 MLN VS LOSS EUR 5.9 MLN YR AGO 

Source text: https://bit.ly/3zdsEVw

Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))